Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Potassium Oxalate Oral Rinse for Dentinal Hypersensitivity
NCT03238352Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 2 trial of dipotassium oxalate in dentin hypersensitivity (DH), sponsored by GSK. Started Aug 2017; status: completed.
02
Drugs
dipotassium oxalate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT03238352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238352.